| Entry |
|
|---|
| Name |
Deoxycoformycin;
Pentostatin
|
|---|
| Formula |
C11H16N4O4
|
|---|
| Exact mass |
268.1172
|
|---|
| Mol weight |
268.27
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX08 Pentostatin
D00155 Pentostatin (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antimetabolites
Pentostatin
D00155 Pentostatin (JAN/USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01500 Adenosine deaminase inhibitor
D00155 Pentostatin
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
D00155 Pentostatin
Drug classes [BR:br08332]
Antineoplastic
DG02018 Antimetabolite
D00155 Pentostatin
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Adenosine deaminase
ADA
D00155 Pentostatin (JAN/USAN/INN) <US>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C1y C 24.9687 -16.6452
2 C1x C 24.5490 -17.9741
3 O2x O 23.8496 -15.8059
4 C1y C 22.7305 -16.6452
5 C1y C 23.1502 -17.9741
6 O1a O 22.3109 -19.0931
7 C1b C 21.4016 -16.1556
8 O1a O 21.1219 -14.8267
9 N4y N 26.2976 -16.2255
10 N2x N 27.3456 -18.5668
11 C8y C 27.3651 -17.0139
12 C8y C 28.4118 -16.1922
13 C1y C 29.9137 -16.5040
14 C2x C 28.5105 -19.3721
15 C1x C 30.4494 -17.7520
16 N1x N 29.8792 -19.0081
17 N5x N 28.0308 -14.9210
18 C8x C 26.5754 -14.9185
19 O1a O 30.7191 -15.3391
BOND 21
1 1 2 1
2 1 3 1
3 3 4 1
4 4 5 1
5 2 5 1
6 5 6 1 #Down
7 4 7 1 #Up
8 7 8 1
9 1 9 1 #Up
10 12 13 1
11 10 14 2
12 13 15 1
13 11 12 2
14 14 16 1
15 10 11 1
16 15 16 1
17 12 17 1
18 17 18 2
19 18 9 1
20 11 9 1
21 13 19 1 #Down
|
|---|
